Analytical Data
-
Gene name
C11orf85
- Application
-
Alternative Names
MAJIN; C11orf85Membrane-anchored junction Protein
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q3KP22
-
Expression Region
1-216aa
-
AA Sequence
MSLKPFTYPF PETRFLHAGP NVYKFKIRYG KSIRGEEIEN KEVITQELED SVRVVLGNLD NLQPFATEHF IVFPYKSKWE RVSHLKFKHG EIILIPYPFV FTLYVEMKWF HENLSPGKPI SDSPLGLVPV EKKAVGAVMR KRKHMDEPSS PSRPGLDRIG KEKPNKDCRR LWPLISLMSR NKILSGDTAC QGELSHPCST THLHLRSEQP PASLGF
-
Molecular Weight
20.0 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
C11orf85, also known as the protein encoded by the chromosome 11 open reading frame 85, has garnered attention in recent years due to its potential role in various biological processes and diseases. While the exact function of C11orf85 remains largely elusive, preliminary studies suggest that it may be involved in cellular signaling pathways and gene regulation. Research has indicated that dysregulation of C11orf85 expression could be linked to certain disorders, including neurodegenerative diseases and cancer. The recombinant form of this protein serves as a valuable tool for studying its structure-function relationships and interactions with other biomolecules. By producing C11orf85 as a recombinant protein, scientists can investigate its biochemical properties, assess its role in cellular mechanisms, and explore its potential as a therapeutic target. Moreover, understanding the molecular characteristics of C11orf85 may provide insights into its physiological relevance and open avenues for novel therapeutic strategies. As research progresses, the investigation of C11orf85 and its recombinant protein is poised to contribute significantly to our comprehension of complex biological systems and the development of targeted interventions for related diseases.
